Literature DB >> 34079721

Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.

Feiqian Wang1,2, Kazushi Numata1, Masahiro Okada3, Makoto Chuma1, Hiromi Nihonmatsu1, Satoshi Moriya1, Akito Nozaki1, Katsuaki Ogushi1, Wen Luo4, Litao Ruan2, Masayuki Nakano5, Masako Otani6, Yoshiaki Inayama6, Shin Maeda7.   

Abstract

BACKGROUND: This study aimed to compare the value of Sonazoid contrast-enhanced ultrasound (SCEUS) with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging (EOB-MRI) for histological grading diagnosis, especially for early hepatocellular carcinoma (eHCC).
METHODS: A total of 163 histopathologically confirmed HCC lesions were retrospectively collected, including 71 eHCCs (27 hypervascular, 44 non-hypervascular) and 92 advanced HCCs (adHCC) (73 hypervascular, 19 non-hypervascular). We performed SCEUS to evaluate the lesions' vascularity during the portal phase (PP) and the echogenicity during the post-vascular phase (PVP). EOB-MRI was used to determine the signal intensity between lesions and the surrounding liver parenchyma on unenhanced T1-weighted images (pre-contrast ratio) in the hepatobiliary phase (HBP) (post-contrast ratio).
RESULTS: For the PP and PVP of SCEUS (for all lesions), the pre-and post-contrast ratios of EOB-MRI (for all hypervascular lesions) showed statistical differences in the diagnosis of some (but not all) histological grades. For the diagnosis of eHCC, isoechogenicity in the PVP achieved the best diagnostic efficacy [area under the receiver operating characteristic curve (AUC) =0.892]. Whether used independently or in a combination of any form, all indicators failed to produce a higher diagnostic efficacy than PVP. Post- (≥0.610) and pre-contrast ratios (≥0.981) yielded acceptable diagnostic efficacy, with, respectively, accuracy levels of 69.3% and 75.5% and AUC values of 0.719 and 0.736. For eHCC diagnosis, the post-contrast ratio (≥0.625) and combined diagnosis using pre- (≥0.907) and post-contrast ratios (≥0.609) revealed the highest sensitivity (92.6%) for hypervascular lesions and perfect specificity (100%) for non-hypervascular lesions.
CONCLUSIONS: Unenhanced T1-weighted images and the HBP of EOB-MRI [regardless of the vascularity in the arterial phase (AP)], and the PP and PVP of SCEUS showed their value in the histological grading diagnosis of HCC. In particular, isoechogenicity in the PVP may have promising diagnostic utility for eHCC. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Diagnosis; Sonazoid contrast-enhanced ultrasound (SCEUS); gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging (EOB-MRI); hepatocellular carcinoma (HCC); histological grade

Year:  2021        PMID: 34079721      PMCID: PMC8107308          DOI: 10.21037/qims-20-685

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  50 in total

Review 1.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

2.  Ultrasound molecular imaging for differentiation of benign and malignant tumors in patients.

Authors:  Fei Yan; Zhuqing Song; Meng Du; Alexander L Klibanov
Journal:  Quant Imaging Med Surg       Date:  2018-12

Review 3.  Terminology of nodular hepatocellular lesions.

Authors: 
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

4.  Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.

Authors:  Hideko Ohama; Yasuharu Imai; Osamu Nakashima; Sachiyo Kogita; Manabu Takamura; Masatoshi Hori; Yasushi Seki; Yoshiyuki Sawai; Takumi Igura; Kazuto Fukuda; Yuki Makino; Osakuni Morimoto; Masahiko Ohsawa; Michiie Sakamoto; Takamichi Murakami
Journal:  J Gastroenterol       Date:  2013-08-01       Impact factor: 7.527

5.  Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.

Authors:  Seun Ah Lee; Chang Hee Lee; Woon Yong Jung; Jongmee Lee; Jae Woong Choi; Kyeong Ah Kim; Cheol Min Park
Journal:  Magn Reson Imaging       Date:  2010-09-15       Impact factor: 2.546

Review 6.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.

Authors:  Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai; Takuji Okusaka; Shiro Miyayama; Kaoru Tsuchiya; Kazuomi Ueshima; Atsushi Hiraoka; Masafumi Ikeda; Sadahisa Ogasawara; Tatsuya Yamashita; Tetsuya Minami; Koichiro Yamakado
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

7.  Pharmacokinetics of Perfluorobutane after Intra-Venous Bolus Injection of Sonazoid in Healthy Chinese Volunteers.

Authors:  Pengfei Li; Susan Hoppmann; Ping Du; Huiling Li; Paul M Evans; Siver A Moestue; Weiyue Yu; Fang Dong; Hongchuan Liu; Lihong Liu
Journal:  Ultrasound Med Biol       Date:  2017-03-07       Impact factor: 2.998

8.  Clinical significance of early hepatocellular carcinoma.

Authors:  Kazuto Inoue; Tadatoshi Takayama; Tokio Higaki; Yoshihiro Watanabe; Masatoshi Makuuchi
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

9.  Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma.

Authors:  Sadahisa Ogasawara; Tetsuhiro Chiba; Tenyu Motoyama; Naoya Kanogawa; Tomoko Saito; Yusuke Shinozaki; Eiichiro Suzuki; Yoshihiko Ooka; Akinobu Tawada; Hideyuki Kato; Shinichiro Okabe; Fumihiko Kanai; Masaharu Yoshikawa; Osamu Yokosuka
Journal:  PLoS One       Date:  2016-09-20       Impact factor: 3.240

Review 10.  Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.

Authors:  Jae Hyun Kim; Ijin Joo; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

View more
  3 in total

1.  Evaluation of liver tumor identification rate of volumetric-interpolated breath-hold images using the compressed sensing method and qualitative evaluation of tumor contrast effect via visual evaluation.

Authors:  Daisuke Yoshimaru; Yoich Araki; Chifumi Matsuda; Natsuhiko Shirota; Yu Tajima; Shuhei Shibukawa; Katsutoshi Murata; Dominik Nickel; Kazuhiro Saito
Journal:  Quant Imaging Med Surg       Date:  2022-05

2.  Diagnostic role of contrast-enhanced ultrasonography versus conventional B-mode ultrasonography in cirrhotic patients with early hepatocellular carcinoma: a retrospective study.

Authors:  Yandong Jiang; Meng Zhang; Yanting Zhu; Dongxiao Zhu
Journal:  J Gastrointest Oncol       Date:  2021-10

3.  Diagnostic accuracy of contrast-enhanced ultrasound for microvascular invasion of hepatocellular carcinoma: A protocol for systematic review and meta-analysis.

Authors:  Yanli Chen; Haiyan Qiao; Zhaoan Lian; Chunlin Li; Yi Xiang
Journal:  Medicine (Baltimore)       Date:  2022-04-15       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.